FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

 
Share
 

Manage episode 200758343 series 1452688
By ReachMD. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.

Released May 22, 2017

153 episodes